Simple questionnaire assesses AMD risk effectively

Researchers in France have developed a simple, largely self-administered, questionnaire which they say effectively assesses risk for age-related macular...

Patients don’t tell docs truth

Most patients withhold information from their doctor, a new study has found.4510 patients participated in two separate but identical surveys. In the respondent...

Biodegradable CLs

National Autonomous University of Mexico (UNAM) experts say they have developed biodegradable lenses for inflammatory eye diseases, which dissolve in minutes...

Anti-VEGF drops a step closer

Anti-VEGF eye drops could soon replace injections, revolutionising treatment for age-related macular degeneration (AMD), with human trials on the cards...

AI picks up early diabetic retinopathy

A team of Australian-Brazilian researchers led by RMIT University in Melbourne has developed an image-processing algorithm that it says can automatically...

New AMD drugs crowd the horizon

A significant number of drugs will launch for the treatment of age-related macular degeneration by 2026, says GlobalData.The age-related macular degeneration...

IOLs and MGD in Wellington

Johnson & Johnson Vision hosted a continuing education evening in Wellington to discuss Meibomian gland dysfunction (MGD) treatment and the Tecnis...

VOSO helps out in Tonga

This year, a small but experienced VOSO team travelled to Tonga. Led by Dr Andrew Riley, the team included optometrists John Tarbutt and myself and Dr...

Bottom Banner Advert